INPUD's survey highlights the devastating effects of foreign aid cuts on harm reduction programming and community networks, calling for emergency funding mechanisms, increased domestic support and intensified advocacy.
C-EHRN's civil society monitoring identifies necessary but unequal progress on treatment and access to services, decrying enduring challenges related to funding, legislation, stigma and political will.
Health Poverty Action proposes restructuring illegal trades to prioritise public health, equity, and sustainability rather than reproducing harmful market practices.
Transform models the spending and revenue outcomes for three post-prohibition market scenarios in the UK, noting potential annual net benefits to the Treasury of up to £1.5 billion.
IDPC, HRI, and Youth RISE highlight how drug policies exacerbate poverty through exclusion from housing, social benefits, education, and employment, reinforcing stigma and discrimination.
HRW denounces human rights violations, including in relation to drug policy ranging from punitive laws to extrajudicial executions, and demands truth and justice.
The Forum addressed transformative strategies for global drug policies, emphasizing human-centered approaches, harm reduction, and sustainable development.
Ahead of the UN CESCR's 77th Session, IDPC supports three bold submissions in Kenya and the UK, assessing their drug policies and human rights records, and demanding urgent reform.
SWAN examines the social justice impact of intersecting identities and provides recommendations for improving services, rights-based programs, and advocacy.
